Jean‐Claude Chermann

13.6k total citations · 4 hit papers
110 papers, 9.8k citations indexed

About

Jean‐Claude Chermann is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Jean‐Claude Chermann has authored 110 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Virology, 46 papers in Infectious Diseases and 40 papers in Immunology. Recurrent topics in Jean‐Claude Chermann's work include HIV Research and Treatment (55 papers), HIV/AIDS drug development and treatment (33 papers) and T-cell and Retrovirus Studies (25 papers). Jean‐Claude Chermann is often cited by papers focused on HIV Research and Treatment (55 papers), HIV/AIDS drug development and treatment (33 papers) and T-cell and Retrovirus Studies (25 papers). Jean‐Claude Chermann collaborates with scholars based in France, United States and Japan. Jean‐Claude Chermann's co-authors include Françoise Barré‐Sinoussi, Luc Montagnier, C. Dauguet, M.T. Nugeyre, S. Chamaret, J Gruest, C. Rouzioux, Willy Rozenbaum, Bruno Spire and David Klatzmann and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jean‐Claude Chermann

109 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1983 4.8k citations Françoise Barré‐Sinoussi, Jean‐Claude Chermann et al. Science profile →
Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes

1984 807 citations Françoise Barré‐Sinoussi, Jean‐Claude Chermann et al. Science profile →
Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines

1984 276 citations Françoise Barré‐Sinoussi, Jean‐Claude Chermann et al. Science profile →
INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHT

1985 222 citations Bruno Spire, Françoise Barré‐Sinoussi et al. The Lancet profile →

Peers

Countries citing papers authored by Jean‐Claude Chermann

Since Specialization

Citations

This map shows the geographic impact of Jean‐Claude Chermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Claude Chermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Claude Chermann more than expected).

Fields of papers citing papers by Jean‐Claude Chermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Claude Chermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Claude Chermann. The network helps show where Jean‐Claude Chermann may publish in the future.

Co-authorship network of co-authors of Jean‐Claude Chermann

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Claude Chermann. A scholar is included among the top collaborators of Jean‐Claude Chermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Claude Chermann. Jean‐Claude Chermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and anti-HIV evaluation of new 2′,3′- dideoxy-3′-thiacytidine prodrugs 2000 ·Nucleosides Nucleotides & Nucleic Acids ·(unknown), Michel Camplo, (unknown), (unknown), D. Ungheri, Jean‐Claude Chermann, Jean‐Louis Kraus	4
2	Synthesis and anti-HIV activity of α-thiophenoxy-hydroxyethylamide derivatives 1999 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Gérard Pèpe, (unknown), Jean‐Claude Chermann, (unknown)	10
3	Syntheses of new modified Phe-Pro peptides. Use of proline replacements in potential HIV inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Jean‐Claude Chermann, Michel Camplo, J.L. Kraus	5
4	Lectin-Mediated Effects on HIV Type 1 Infection in Vitro 1995 ·AIDS Research and Human Retroviruses ·Lena Marmstål Hammar, Ivan Hirsch, Alcyone Artioli Machado, (unknown), (unknown), (unknown), Jean‐Claude Chermann	21
5	HIV Tat protein potentiates in vitro granulomonocytic progenitor cell growth 1995 ·European Journal Of Haematology ·V. Calenda, Jean‐Claude Chermann	7
6	Characterization of HIV1-PAR, a macrophage-tropic strain: cell tropism, virus/cell entry and nucleotide sequence of the envelope glycoprotein 1993 ·Research in Virology ·Helena Schmidtmayerova, Odile Gayet, (unknown), (unknown), Ivan Hirsch, Jean‐Claude Chermann	3
7	Effects of thymus humoral factor gamma-2 (THFγ2) on lymphohaematopoietic progenitor cells: An in vitro study 1993 ·Research in Immunology ·V. Calenda, Françoise Silvy, Jean‐Claude Chermann	3
8	Thegagprecursor contains a specific HIV‐1 protease cleavage site between the NC (P7) and P1 proteins 1993 ·FEBS Letters ·Ewald M. Wondrak, John M. Louis, Hugues de Rocquigny, Jean‐Claude Chermann, Bernárd P. Roques	36
9	Cellular Proteins Bound to Immunodeficiency Viruses: Implications for Pathogenesis and Vaccines 1992 ·Science ·Larry O. Arthur, Julian W. Bess, Raymond C. Sowder, Raoul Ė. Benveniste, Dean L. Mann, Jean‐Claude Chermann, Louis E. Henderson	456
10	Modulation of Normal Human Erythropoietic Progenitor Cells in Long-Term Liquid Cultures After HIV-1 Infection 1992 ·AIDS Research and Human Retroviruses ·V. Calenda, G Sébahoun, Jean‐Claude Chermann	17
11	The effects of HIV on hematopoiesis 1992 ·European Journal Of Haematology ·V. Calenda, Jean‐Claude Chermann	50
12	HIV1 cytopathogenicity-genetic difference between direct cytotoxic and fusogenic effect 1992 ·Virology ·Ivan Hirsch, Danièle Salaün, Beda Břicháček, Jean‐Claude Chermann	16
13	Severe in vitro inhibition of erythropoiesis and transient stimulation of granulopoiesis after bone-marrow infection with eight different HIV-2 isolates 1992 ·AIDS ·V. Calenda, Jean‐Claude Chermann	10
14	Fetal Human Immunodeficiency Virus Type 1 Infection of Different Organs in the Second Trimester 1991 ·AIDS Research and Human Retroviruses ·(unknown), Jean‐Claude Chermann	75
15	Differential HIV replication and HIV-induced interferon production in mononuclear phagocytes: relationship to cell maturation 1991 ·Research in Virology ·(unknown), Ferenc Tóth, Vladimir Zachar, (unknown), Niels Nørskov‐Lauritsen, George Aboagye‐Mathiesen, Jean‐Claude Chermann, Peter Ebbesen	10
16	Anti-β2-microglobulin monoclonal antibodies mediate a delay in HIV1 cytopathic effect on MT4 cells 1990 ·Research in Immunology ·Christian Devaux, José Boucraut, Gary R. Poirier, Pierre Corbeau, F.A. Rey, Monsef Benkirane, Beatrice Pérarnau, F. M. Kourilsky, Jean‐Claude Chermann	14
17	Characterization of monoclonal antibodies directed against distinct conserved epitopes of human immunodeficiency virus type 1 core proteins 1990 ·Molecular and Cellular Biochemistry ·Masashi Tatsumi, Christian Devaux, (unknown), Jean‐Claude Chermann	10
18	Differential inhibition of various mammalian DNA polymerase activities by ammonium 21‐tungsto‐9‐antimoniate (HPA23) 1988 ·European Journal of Biochemistry ·Katsuhiko Ono, Hideo Nakane, (unknown), Jean‐Claude Chermann	17
19	ACQUIRED IMMUNODEFICIENCY SYNDROME AFTER TRAVELLING IN AFRICA: AN EPIDEMIOLOGICAL STUDY IN SEVENTEEN CAUCASIAN PATIENTS 1987 ·The Lancet ·Daniel Vittecoq, R Roué, C Mayaud, (unknown), M. Armengaud, Brigitte Autran, T. May, M. Stern, P. Chavanet, (unknown), J Modaï, F.A. Rey, Jean‐Claude Chermann	28
20	GENOMIC VARIABILITY OF SELECTED LAV-RELATED AIDS RETROVIRUSES 1986 ·PubMed ·(unknown), Bruno Spire, Françoise Barré‐Sinoussi, Jean‐Claude Chermann	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact